David Spector, Angel Investor

David Spector is the Co-Founder of Nanotrace, a company pioneering oncology platforms that combine chemotherapy, nanoparticle delivery, and gene therapeutics. He is also Chairman and Co-Founder of ThirdLove, which he helped grow into one of the largest online intimates brands in the U.S., recognized for its technology-driven design and patented innovations. Previously, David worked with Sequoia Capital, Google, and MIT before building ThirdLove into a profitable, scalable commerce platform. He also serves on the IAB Board of Directors and has held advisory roles with companies like SAP Roambi, reflecting his focus on technology, product development, and organizational growth. As an angel investor, Spector has made about twenty-five investments across consumer, healthtech, and frontier technology. His recent portfolio includes BluePill, Capchase, Attentive, and Relativity Space, highlighting his interest in startups that combine innovation, scalability, and strong founder-driven execution.